Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 326 clinical trials
  • 82 views
  • 25 Apr, 2021
  • 12 locations
A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients

active to warrant further investigation in randomized phase II or III studies. Metastatic renal cell cancer (mRCC) patients with PD-1 expressing immune cells are more likely to have larger more

  • 0 views
  • 30 Mar, 2021
  • 3 locations
  • 70 views
  • 08 May, 2021
  • 16 locations
NPC - AXEL Study : Axitinib-Avelumab

recurrent or metastatic NPC who failed at least first line chemotherapy. The combination of axitinib and avelumab has been studied in renal cell carcinoma (RCC). Based on the above promising and

  • 0 views
  • 14 May, 2021
  • 1 location
Salvage Therapy With Sunitinib Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

sutent was approved to effective by two phase II trials in advanced renal cell carcinoma patients after failure of immunotherapies, and one phase III trial in treatment-naive advanced renal

serum bilirubin level
docetaxel
lung carcinoma
measurable disease
cancer chemotherapy
  • 2 views
  • 08 Nov, 2020
  • 1 location
Anesthesia and Cancer Study: Renal Cell Carcinoma

This study investigates the influence of type of anesthesia on recurrence and survival of renal cell carcinoma in patients undergoing nephrectomy. The participants will be allocated to either

nephrectomy
cancer
carcinoma
anesthesia
  • 0 views
  • 25 Jan, 2021
  • 1 location
A Phase 1 Study With ABBV-CLS-484 in Subjects With Locally Advanced or Metastatic Tumors

refractory non-small cell lung cancer (NSCLC), and advanced clear cell renal cell carcinoma (ccRCC). ABBV-CLS-484 will also be administered at the determined recommended dose in combination with a PD-1

  • 0 views
  • 19 Jun, 2021
  • 5 locations
Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC

Combination treatment of Durvalumab with chemoradiotherapy is ongoing for head/neck cancer, renal cell carcinoma, melanoma, and non-small cell lung cancer (NCT02318771) and pancreatic cancer

  • 0 views
  • 23 Jan, 2021
  • 1 location
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)

activity for cabozantinib in patients with advanced renal cell carcinoma and metastatic castration-resistant prostate cancer (mCRPC). Furthermore, in preclinical models of urothelial carcinoma (UC) of the

transitional cell carcinoma
kinase inhibitor
measurable disease
gilbert's disease
pd-l1
  • 46 views
  • 26 Jan, 2021
  • 12 locations
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)

participants with previously untreated advanced/metastatic non-clear cell renal cell carcinoma.

progressive disease
lenvatinib
clear cell renal cell carcinoma
measurable disease
pembrolizumab
  • 0 views
  • 20 Jun, 2021
  • 42 locations